All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.
Research output: Book/Report › Commissioned report
| Original language | English |
|---|---|
| Publisher | Unknown |
| Commissioning body | NHS Wales |
| Edition | 2009 |
| Publication status | Published - 1 Jan 2009 |